A citation-based method for searching scientific literature

Achim Rittmeyer, Fabrice Barlesi, Daniel Waterkamp, Keunchil Park, Fortunato Ciardiello, Joachim von Pawel, Shirish M Gadgeel, Toyoaki Hida, Dariusz M Kowalski, Manuel Cobo Dols, Diego L Cortinovis, Joseph Leach, Jonathan Polikoff, Carlos Barrios, Fairooz Kabbinavar, Osvaldo Arén Frontera, Filippo De Marinis, Hande Turna, Jong-Seok Lee, Marcus Ballinger, Marcin Kowanetz, Pei He, Daniel S Chen, Alan Sandler, David R Gandara. Lancet 2017
Times Cited: 2364



Mark Ayers, Jared Lunceford, Michael Nebozhyn, Erin Murphy, Andrey Loboda, David R Kaufman, Andrew Albright, Jonathan D Cheng, S Peter Kang, Veena Shankaran, Sarina A Piha-Paul, Jennifer Yearley, Tanguy Y Seiwert, Antoni Ribas, Terrill K McClanahan. J Clin Invest 2017
Times Cited: 1098




List of shared articles



Times cited


The cutting-edge progress of immune-checkpoint blockade in lung cancer.
Fei Zhou, Meng Qiao, Caicun Zhou. Cell Mol Immunol 2021
5

Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation.
Wei Nie, Lu Gan, Xin Wang, Kai Gu, Fang-Fei Qian, Min-Juan Hu, Ding Zhang, Shi-Qing Chen, Jun Lu, Shu-Hui Cao,[...]. Oncoimmunology 2021
0

Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC.
Mengke Niu, Ming Yi, Ning Li, Suxia Luo, Kongming Wu. Exp Hematol Oncol 2021
6


PTEN loss correlates with T cell exclusion across human cancers.
Ziying Lin, Lixia Huang, Shao Li Li, Jincui Gu, Xiaoxian Cui, Yanbin Zhou. BMC Cancer 2021
1

Classification of Non-Small Cell Lung Cancer's Tumor Immune Micro-Environment and Strategies to Augment Its Response to Immune Checkpoint Blockade.
Alexander Chi, Xia He, Lin Hou, Nam P Nguyen, Guangying Zhu, Robert B Cameron, Jay M Lee. Cancers (Basel) 2021
1

The Value of Population Screening in Advancing Personalized Medicine in the Field of Lung Cancer.
Alice Mogenet, Laurent Greillier, Pascale Tomasini. Pharmgenomics Pers Med 2021
1